GraMedica® Announces the Selection of Al Seef Hospital as a HyProCure® Intl Center of Excellence
A significant number of children and adults suffer lack of mobility and pain from excessive hindfoot motion, also known as hyperpronation, a surgically correctable condition that results in the misalignment of the foot and other major structures of the body. The minimally invasive HyProCure® EOTTS procedure provides many patients with immediate and permanent correction for hyperpronation. Left untreated, this condition can lead to serious, long-term foot, knee, hip, and back related issues that often require much more aggressive forms of surgery.
The experienced orthopedic bone surgeons at Al Seef led by Head of Orthopedic, Dr. Youssef Koleilat, use a holistic approach to treating the musculoskeletal system. They were the first to introduce the HyProCure® procedure to the Middle East. Al Seef’s orthopedic group combines current evidence-based medical knowledge with cutting edge surgical and implant technologies to diagnose, treat and manage disorders and conditions of the musculoskeletal system. Through surgical interventions, rehabilitative therapy and medications, our team provides optimized and personalized patient care for degenerative diseases, musculoskeletal trauma and injuries.
GraMedica® is the Macomb, Michigan developer and manufacturer of HyProCure®, a surgical stent that has been used in over 26,000 procedures worldwide to treat hyperpronation. HyProCure® International Centers of Excellence is a program to reach out to a large patient population, designed to increase the awareness and medical services provided by experts in foot and ankle care.
Future announcements are expected regarding GraMedica’s HyProCure® International Centers of Excellence located in other parts of the world.
For more information
Web: http://www.gramedica.com | http://www.hyprocure.com | http://alignmyfeet.com
International Sales, GraMedica